Correlation Between Invesco Health and Allianz Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Invesco Health and Allianz Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invesco Health and Allianz Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Invesco Health Care and Allianz Technology Trust, you can compare the effects of market volatilities on Invesco Health and Allianz Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invesco Health with a short position of Allianz Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invesco Health and Allianz Technology.

Diversification Opportunities for Invesco Health and Allianz Technology

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Invesco and Allianz is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Invesco Health Care and Allianz Technology Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allianz Technology Trust and Invesco Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invesco Health Care are associated (or correlated) with Allianz Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allianz Technology Trust has no effect on the direction of Invesco Health i.e., Invesco Health and Allianz Technology go up and down completely randomly.

Pair Corralation between Invesco Health and Allianz Technology

Assuming the 90 days trading horizon Invesco Health Care is expected to under-perform the Allianz Technology. But the etf apears to be less risky and, when comparing its historical volatility, Invesco Health Care is 1.93 times less risky than Allianz Technology. The etf trades about -0.21 of its potential returns per unit of risk. The Allianz Technology Trust is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  36,950  in Allianz Technology Trust on August 25, 2024 and sell it today you would earn a total of  2,850  from holding Allianz Technology Trust or generate 7.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Invesco Health Care  vs.  Allianz Technology Trust

 Performance 
       Timeline  
Invesco Health Care 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invesco Health Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Etf's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the exchange-traded fund private investors.
Allianz Technology Trust 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Allianz Technology Trust are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Allianz Technology may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Invesco Health and Allianz Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Invesco Health and Allianz Technology

The main advantage of trading using opposite Invesco Health and Allianz Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invesco Health position performs unexpectedly, Allianz Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allianz Technology will offset losses from the drop in Allianz Technology's long position.
The idea behind Invesco Health Care and Allianz Technology Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance